Catalyst Wire Dossier Catalyst Wire Dossier

TAXUS Liberté Stent

paclitaxel-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAXUS Liberté Stent, covering 2012-02-02 to 2012-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions [Phase 3]

See pricing